Journey Medical

DERM · NASDAQ

$5.22+$0.05 (+0.97%)TodayMarket closed ·
Prev close $5.17

Who owns DERM

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 60.5% of DERM’s shares.

  • Fortress Biotech Inc15.6%
  • Wasatch Global Investors Inc13.3%
  • Maraoui (Claude)10.6%
  • Tang Capital Management, LLC7.5%
  • Next 6 largest institutions13.5%
  • All other shareholders39.5%
Top institutional holders of DERM
HolderShares% of shares
Fortress Biotech Inc3.36M15.61%
Wasatch Global Investors Inc2.86M13.28%
Maraoui (Claude)2.29M10.64%
Tang Capital Management, LLC1.61M7.48%
Vanguard Capital Management, LLC675.18K3.14%
Punch & Associates Investment Management, Inc.536.00K2.49%
Pale Fire Capital SE528.58K2.46%
Alloush (Ramsey)470.73K2.19%
Opaleye Management Inc.350.00K1.63%
Summit Financial, LLC346.75K1.61%

Largest mutual fund holders

Top mutual fund holders of DERM
HolderShares% of shares
Wasatch Micro Cap Fund1.38M6.43%
Wasatch Micro Cap Value Fund814.35K3.78%
Vanguard Total Stock Market Index Fund470.43K2.18%
Vanguard Extended Market Index Fund186.97K0.87%
Fidelity Extended Market Index Fund80.90K0.38%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of DERM in the last 6 months.

Latest DERM insider transactions
InsiderTypeSharesValue
Smith Justin AdamAward50.00K—
Toledano Miranda JayneAward50.00K—
Herskowitz NeilAward50.00K—
Smith Justin AdamAward10.00K—
ROSENWALD LINDSAY A MDAward10.00K—
Pearce Michael CooperAward10.00K—
Herskowitz NeilAward10.00K—
Alloush RamseyAward62.80K—
Alloush RamseyAward46.86K—
Benesch JosephAward41.86K—

Short interest

Settled Sep 30, 2026

Shares short
3.06M
Days to cover
13.91
% of shares outstanding
14.19%
Average daily volume
219.73K
Change since last report
+4.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.